Should Paxlovid be prescribed for patients with severe COVID‐19 in the late course of infection? A case report

Should Paxlovid be prescribed for patients with severe COVID‐19 in the late course of infection? A case report

Abstract The infection of the coronavirus disease 2019 (COVID‐19) is often accompanied by pneumonia with both high incidence and mortality. Paxlovid is commonly prescribed in patients with mild and normal pneumonia within 5 days from the symptom onset. Herein, we report a practically effective use o...

Full description

Bibliographic Details
Main Authors: Qiang Li, Yibo He, Jin Liu, Xiaozhao Lu, Ziyou Zhou, Yu Kang, Wanying Wu, Jielan Wu, Feng Wang, Yinghao Sun, Wei Wang, Chengyi Hui, Wenting Wei, Miaoyun Wen, Jingjing Chen, Yong Liu
Format: Article
Language:English
Published: Wiley 2023-03-01
Series:Medicine Advances
Subjects:
COVID‐19
case report
severe pneumonia
Paxlovid
Online Access:https://doi.org/10.1002/med4.12

Internet

https://doi.org/10.1002/med4.12

Similar Items